Endocrinologist Raimund Herzog said: “Unfortunately, there are currently only very few drugs that lower insulin levels.
“If our ongoing clinical trials confirm the promise of the preclinical studies reported in this paper, and ultrasound can be used to lower both insulin and glucose levels, ultrasound neuromodulation would represent an exciting and entirely new addition to the current treatment options for our patients.”
Should trials prove successful, this form of ultrasound could prove useful to the NHS in its treatment of type two diabetes.
Type two diabetes currently makes up around 90 percent of diabetes cases in the UK.
